Cases & Deals

AstraZeneca establishes IP protection program in China

Clients AstraZeneca LP

Jones Day advised AstraZeneca LP on IP strategies for China; provided advice on patenting strategies, protection of trade secrets, and non-compete agreements.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.